Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world... Show more
IBM has spent nearly a decade repositioning itself around hybrid cloud, data, and AI, moving away from commoditized hardware toward a recurring, software-heavy revenue model. That positioning is now the core of the company's market profile: Red Hat provides an open hybrid-cloud platform spanning public cloud, on-premises, and edge environments, while the 2026 acquisition of Confluent strengthens its real-time data layer and HashiCorp and Apptio address automation, security, and cost optimization.
The competitive logic is that most enterprise data still sits outside the public cloud, and enterprises increasingly want to run AI workloads on infrastructure they control. IBM's pitch—open, secure, and cost-efficient enterprise AI—targets exactly that demand. OpenShift has grown into a roughly $2.4 billion ARR business expanding at more than 30%, and AI now represents about 30% of consulting revenue and 35% of the consulting backlog, suggesting the services arm is following clients into AI-enabled transformation rather than standing apart from it.
Structural risks remain, however. IBM competes against hyperscalers and pure-play software vendors with faster organic growth, and its consulting segment has shown only modest revenue growth with some margin pressure. The company's medium-term outlook depends on sustaining software growth without leaning on mergers and acquisitions (M&A) or one-time mainframe demand.
The most consequential upcoming event is IBM's fourth-quarter earnings report, expected in late January 2027, where management is anticipated to provide initial 2027 guidance. Investors will focus on whether software growth—guided to 7%–8% for 2026—can hold at a high-single-digit pace once the boost from recovered second-quarter deals and the strong z17 mainframe program-to-date revenue, which has exceeded the prior cycle by more than $1 billion, begins to normalize.
Other catalysts include the continued integration and cross-sell of Confluent, highlighted by the Streamhouse real-time data capability; the scaling of Lightwell, an open-source remediation offering whose pipeline is already approaching $700 million; and incremental quantum-computing milestones. Capital allocation also matters: IBM has raised its dividend for 31 consecutive years, most recently to $1.69 per share, and has guided to more than $1 billion of free cash flow growth for 2026.
On the analyst front, sentiment remains cautiously constructive. The consensus is a "Moderate Buy," with 12-month price targets clustering in the $250–$300 range. Following third-quarter results, several firms lifted targets—Goldman Sachs to $300, Stifel to $260, and Susquehanna to $256—while others, such as UBS, held a more neutral stance, citing estimate risk into 2027. The direction of future revisions will likely track the durability of software growth.
IBM's trajectory is closely tied to enterprise technology spending cycles, which are in turn sensitive to interest rates and inflation. Higher financing costs can delay large, multi-year IT projects—precisely the kind of contracts that weighed on IBM's second quarter before recovering in the third. Currency fluctuations also matter, since IBM reports a meaningful share of revenue outside the United States and guides on a constant-currency basis.
A defining macro theme is the evolving economics of enterprise AI. While AI adoption is accelerating, IBM's leadership has acknowledged that corporate clients are scrutinizing whether AI investments generate measurable returns. This shift favors vendors that can demonstrate cost efficiency and governance, which is central to IBM's messaging. At the same time, growing emphasis on sovereign AI and data control is pushing some workloads toward on-premises and hybrid architectures—a structural tailwind for IBM's model, even as it raises implementation complexity and cost for clients.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders assess whether a stock, exchange-traded fund (ETF), or other asset may move bullish, bearish, or sideways over the coming week or month. The platform is built to surface developing trends, evaluate possible breakouts or reversals, and support exploration across a wide range of tradable instruments, with searchable prediction categories, historical context, and alert-oriented functionality. For investors tracking IBM's evolving software and AI story, it offers a data-driven complement to fundamental analysis. Consider exploring the Trend Prediction Engine to see how its forecasts align with your own research.
For the remainder of 2026, IBM has guided to constant-currency revenue growth of 4%–5%, roughly 100 basis points of operating pre-tax margin expansion, and more than $1 billion of free cash flow growth. The open question for 2027 and beyond is whether software can sustain high-single-digit growth organically, or whether momentum depends on recovered deals and acquisition contributions.
Longer-term themes center on the maturation of enterprise AI, the shift toward hybrid and sovereign computing, and the monetization of data infrastructure. Confluent and Red Hat position IBM to capture demand as enterprises move from isolated AI pilots to AI operating at scale. Margin sustainability will hinge on the company's productivity program, which has already delivered billions in savings, and on consulting's ability to reprice and scale AI work. Competitive threats from hyperscalers, a fading mainframe tailwind, and regulatory scrutiny of AI are the principal watch items. While analyst price targets suggest modest upside from current levels, they should be read as external expectations rather than the article's own forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, IBM has been loosely correlated with GIB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IBM jumps, then GIB could also see price increases.
| Ticker / NAME | Correlation To IBM | 1D Price Change % |
|---|---|---|
| IBM | 100% | +1.01% |
| Technology Services category (396 stocks) | 26% Poorly correlated | -0.36% |
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices
On November 11, 2026, the Stochastic Oscillator for IBM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 56 instances where the indicator left the oversold zone. In 39 of the 56 cases the stock moved higher in the following days. This puts the odds of a move higher at over 70%.
IBM moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IBM crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +1.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in 249 of 375 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 164 of 271 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The 10-day RSI Indicator for IBM moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In 29 of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBM as a result. In 44 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 54%.
The Moving Average Convergence Divergence Histogram (MACD) for IBM turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 23 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
IBM broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. IBM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.700) is normal, around the industry mean (2.898). P/E Ratio (21.379) is within average values for comparable stocks, (18.492). Projected Growth (PEG Ratio) (2.087) is also within normal values, averaging (2.284). Dividend Yield (0.028) settles around the average of (0.224) among similar stocks. P/S Ratio (3.271) is also within normal values, averaging (139.965).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.